McKean, M., Haydon, A., Frentzas, S., Hu-Lieskovan, S., Souza, P. L. D., Powderly, J. D., Rasco, D. W., Weickhardt, A. J., Kichenadasse, G., Ganju, V., Lakhani, N. J., Oakman, C. A., Yorio, J. T., Govindan, R., Ward, J., Wyant, T., Richards, L., Knickerbocker, A., Ofran, Y., Vasselli, J. R. (2026). Imneskibart + low-dose subcutaneous IL-2 ± nivolumab in patients with CPI-refractory cutaneous melanoma: Promising results from an ongoing phase 1/2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9526